Cervical cancer once killed tens of thousands of women every year in countries with widespread HPV vaccination programs. Now, new data reported by New Scientist shows those deaths have plummeted — and the HPV vaccine is the reason why.

What the Numbers Actually Show

In England, cervical cancer rates among women who received the HPV vaccine as teenagers dropped by as much as 87 percent compared to unvaccinated groups, according to research tracking outcomes since the UK's national vaccination program launched in 2008. The study, published in The Lancet, followed hundreds of thousands of women born between 1988 and 1995 — the first generations to receive the vaccine at scale.

That's not a modest improvement. That's near-elimination of a cancer that still kills roughly 340,000 women globally each year, according to the World Health Organization.

Why This Matters Beyond Cervical Cancer

HPV doesn't just cause cervical cancer. The same high-risk strains — primarily HPV-16 and HPV-18 — drive cancers of the throat, anus, penis, vulva, and vagina. That means this vaccine's impact stretches far beyond one diagnosis.

We've covered how the HPV vaccine cuts cancer risk in men by 50% — and that data holds. Oropharyngeal cancers, which are now more common in men than women in the US, are overwhelmingly linked to HPV-16 infection acquired through sexual contact.

If you're living with HPV, you already know this virus doesn't follow a simple script. These findings matter to you — not just to teenagers in school vaccination programs.

The Vaccine Works Best Early — But Adults Aren't Out of Options

The most dramatic protection comes when the vaccine is given before any HPV exposure, which is why it's recommended for preteens. But the CDC currently approves Gardasil 9 for adults up to age 45, and the CDC's guidance notes that even adults with prior HPV exposure can benefit — because the vaccine protects against strains they may not yet have encountered.

If you're in your 20s, 30s, or early 40s and haven't been vaccinated, that conversation with your doctor is worth having. Not because you're required to. Because you have options.

"The impact of the HPV vaccination program has been even more impressive than we hoped. We are seeing the beginnings of the elimination of cervical cancer in younger women."

— Professor Peter Sasieni, King's College London, commenting on the Lancet study findings

What This Means for the HPV-Positive Community

If you've already tested positive for HPV, you can't undo a current infection with the vaccine. We want to be straight with you about that. But many people carry one strain and haven't been exposed to others. The vaccine can still offer real protection.

We also know that for many of you reading this, the emotional weight of an HPV diagnosis goes beyond the medical facts. The stigma around any sexually transmitted infection shapes how people feel about their bodies, their relationships, and their futures. This data pushes back hard against the narrative that HPV is something to be ashamed of or resigned to — it's something medicine is actively, measurably conquering.

We've written before about how the HPV vaccine cuts cervical cancer risk to near zero in vaccinated populations. Today's findings confirm that promise isn't theoretical anymore. It's showing up in real mortality data, in real communities, in women who are alive today because a vaccine existed.

The Gap That Still Needs Closing

Here's where the story gets harder. The vaccine works. The data is overwhelming. And yet global vaccination rates remain uneven — shaped by access, misinformation, healthcare infrastructure, and yes, stigma around sexual health.

In lower-income countries, where cervical cancer rates are highest and screening resources are thinnest, vaccination coverage lags far behind. The WHO's goal to vaccinate 90 percent of girls worldwide by age 15 by 2030 is still far from reached.

So while we celebrate what's working, we can't ignore what isn't. A vaccine that exists but doesn't reach people isn't doing its job.

For the MeetPositives community — people who live with HPV, who understand what it means to carry a diagnosis that the world misunderstands — this research lands differently. It's proof that science moves. It's proof that investment in sexual health saves lives. And it's a reminder that the stigma attached to these infections costs something real: it delays care, discourages vaccination, and keeps people from having conversations that could protect them. You know better than most what that silence costs. Share this data. Talk to your doctor. And know that the science is on your side.